Both in Diagnostics
Idexx Laboratories vs Celldex Therapeutics
Over the past year IDXX returned −16.1% and CLDX returned +20.2%; their daily moves had a correlation of 0.09.
IDXX −16.1% CLDX +20.2%Growth of $1, one year, split-adjusted
| Metric | IDXX | CLDX |
|---|---|---|
| Price | $529.06 | $31.49 |
| Market cap | $41.68B | $2.47B |
| Today | +1.89% | +1.25% |
| 1 month | −2.9% | −22.2% |
| 6 months | −5.2% | +3.9% |
| Year to date | −21.8% | +15.9% |
| 1 year | −14.4% | +24.7% |
| Revenue growth (YoY) | +9.7% | −97.0% |
| Gross margin | 64.0% | 100.0% |
| Net margin | 27.8% | −334104.5% |
| P/E (TTM) | 36.6× | — |
| Price / sales | 9.2× | 15,651.2× |
| Net cash | -$771.9M | $717.6M |
| Dividend yield | — | — |
| Volatility (60d) | 27.0% | 47.6% |
| Short % of float | 2.4% | 12.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).